Clinical trial
VALID: VAlproate Versus LIthium in Bipolar Disorders
NCT00264173 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00264173 |
|---|---|
| Title | VALID : VAlproate Versus LIthium in Bipolar Disorders |
| Official title | A Twelve-Week, Open, Randomized Trial Comparing Valproate to Lithium in Bipolar I Patients Suffering From a Manic Episode |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Valproate sodium |
| Enrollment | 270 |
| Start date | Feb 1, 2004 |
| Completion | Sep 1, 2006 |
| First posted | Dec 12, 2005 |
| Last update posted | Nov 16, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: